China Biologic Products Holdings, Inc. CBPO
$ 119.99
1.68%
China Biologic Products Holdings, Inc. Financial Ratios 2011-2024 | CBPO
Annual Financial Ratios China Biologic Products Holdings, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
P/E |
29.9 | 32.4 | 21.6 | 32.7 | 29.0 | 36.9 | 23.5 | 14.0 | 11.2 | 13.3 |
P/S |
8.7 | 8.9 | 5.9 | 6.0 | 8.9 | 11.1 | 6.8 | 3.8 | 2.7 | 1.6 |
EV/EBITDA |
17.4 | 22.8 | 14.3 | 13.5 | 18.3 | 22.2 | 14.1 | 7.0 | 4.6 | 2.5 |
PEG |
2.73 | 114.53 | 0.45 | -0.89 | 2.53 | 1.91 | 0.6 | 0.76 | 0.08 | -0.29 |
P/B |
2.2 | 2.5 | 1.5 | 3.3 | 5.8 | 7.0 | 6.0 | 2.5 | 2.0 | 1.4 |
P/CF |
19.2 | 21.9 | 41.1 | 34.8 | 42.1 | 57.5 | 23.2 | 14.5 | 11.8 | 8.1 |
ROE % |
7.32 | 7.82 | 6.94 | 10.23 | 20.11 | 19.07 | 25.76 | 17.96 | 17.57 | 10.16 |
ROA % |
6.74 | 7.16 | 6.37 | 8.40 | 17.32 | 16.15 | 15.87 | 13.52 | 14.54 | 7.31 |
ROCE % |
9.21 | 9.00 | 7.74 | 19.10 | 27.08 | 27.63 | 34.08 | 25.54 | 28.29 | 31.47 |
DSO |
105.9 | 72.7 | 97.8 | 121.4 | 36.3 | 31.0 | 29.1 | 31.0 | 22.1 | 46.1 |
DIO |
530.4 | 523.9 | 605.0 | 609.4 | 460.3 | 433.3 | 462.1 | 494.0 | 469.5 | 565.8 |
DPO |
9.2 | 13.1 | 28.4 | 22.0 | 18.1 | 33.2 | 22.0 | 24.8 | 18.0 | 39.6 |
All numbers in USD currency